$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$145.91M
Market Cap
-
P/E Ratio
-0.3
EPS
$2.66
52 Week High
$1.13
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Compugen Ltd. (CGEN) is a pioneering clinical-stage biotechnology firm dedicated to developing innovative therapeutics for cancer and autoimmune disorders. Utilizing its advanced computational discovery platform, the company is actively advancing a diverse pipeline of immuno-oncology candidates that target critical pathways in the tumor microenvironment. Headquartered in Holon, Israel, Compugen is well-positioned to capitalize on international opportunities, particularly in the U.S. and Europe, as it seeks to transform treatment paradigms and improve patient outcomes in oncology and related therapeutic areas.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG